The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study. MK-4482, delivered orally, is now in human clinical trials.
from Top Health News -- ScienceDaily https://ift.tt/3wXH0Hj
No comments:
Post a Comment